603233 大参林
已收盘 07-01 15:00:00
资讯
新帖
简况
大参林(603233)披露可转债转股结果暨股份变动公告,7月1日股价上涨7.45%
证券之星 · 07-01 23:13
大参林(603233)披露可转债转股结果暨股份变动公告,7月1日股价上涨7.45%
7月1日大参林涨7.45%,兴全有机增长混合基金重仓该股
证券之星 · 07-01 16:35
7月1日大参林涨7.45%,兴全有机增长混合基金重仓该股
大参林涨7.45%,中邮证券二个月前给出“买入”评级
证券之星 · 07-01 16:35
大参林涨7.45%,中邮证券二个月前给出“买入”评级
大参林(603233)披露2025年度可转债受托管理事务报告,6月29日股价上涨4.59%
证券之星 · 06-29 22:38
大参林(603233)披露2025年度可转债受托管理事务报告,6月29日股价上涨4.59%
每周股票复盘:大参林(603233)主体信用评级维持AA
证券之星 · 06-28
每周股票复盘:大参林(603233)主体信用评级维持AA
6月26日XD大参林创60日新低,兴全有机增长混合基金重仓该股
证券之星 · 06-26
6月26日XD大参林创60日新低,兴全有机增长混合基金重仓该股
每周股票复盘:大参林(603233)每股派息0.49元6月26日发放
证券之星 · 06-20
每周股票复盘:大参林(603233)每股派息0.49元6月26日发放
大参林(603233)披露2025年年度权益分派实施公告,6月17日股价下跌3.13%
证券之星 · 06-17
大参林(603233)披露2025年年度权益分派实施公告,6月17日股价下跌3.13%
大参林跌3.13% 中泰证券国金证券华西证券高位喊买入
中金财经 · 06-17
大参林跌3.13% 中泰证券国金证券华西证券高位喊买入
濮阳大参林某门店登通报 售卖中药熏蒸仪抽检不合格
中金财经 · 06-03
濮阳大参林某门店登通报 售卖中药熏蒸仪抽检不合格
每周股票复盘:大参林(603233)为8家子公司担保4.35亿元
证券之星 · 05-31
每周股票复盘:大参林(603233)为8家子公司担保4.35亿元
大参林(603233)披露对子公司提供担保的进展公告,5月27日股价下跌2.82%
证券之星 · 05-27
大参林(603233)披露对子公司提供担保的进展公告,5月27日股价下跌2.82%
每周股票复盘:大参林(603233)2025年年度股东会顺利召开
证券之星 · 05-24
每周股票复盘:大参林(603233)2025年年度股东会顺利召开
大参林(603233)披露2025年年度股东会决议公告,5月18日股价下跌5.42%
证券之星 · 05-18
大参林(603233)披露2025年年度股东会决议公告,5月18日股价下跌5.42%
大参林跌5.42% 华创证券上周四刚维持推荐评级
中金财经 · 05-18
大参林跌5.42% 华创证券上周四刚维持推荐评级
5月18日大参林跌5.42%,兴全有机增长混合基金重仓该股
中金财经 · 05-18
5月18日大参林跌5.42%,兴全有机增长混合基金重仓该股
每周股票复盘:大参林(603233)2025年净利增35.04%
证券之星 · 05-10
每周股票复盘:大参林(603233)2025年净利增35.04%
大参林(603233)披露2025年度股东会会议材料,5月8日股价上涨0.32%
证券之星 · 05-08
大参林(603233)披露2025年度股东会会议材料,5月8日股价上涨0.32%
中邮证券:给予大参林买入评级
证券之星 · 04-28
中邮证券:给予大参林买入评级
股市必读:大参林年报 - 第四季度单季净利润同比增长172.37%
证券之星 · 04-27
股市必读:大参林年报 - 第四季度单季净利润同比增长172.37%
加载更多
公司概况
公司名称:
大参林医药集团股份有限公司
所属行业:
零售业
上市日期:
2017-07-31
主营业务:
大参林医药集团股份有限公司的主营业务是中西成药、参茸滋补药材及中药饮片、保健品、医疗器械及其他商品的连锁零售业务。公司的主要产品是中西成药、中参药材、非药品。公司荣获的社会地位及行业荣誉:“大参林”已成为“中国驰名商标”和“广东省著名商标”。公司业务范围覆盖广东、广西、河南、黑龙江、江苏、新疆、辽宁、四川、重庆、河北、陕西、江西、山西、浙江、湖北、山东、福建、安徽、海南、上海、内蒙古等21个省(含自治区、直辖市),其中,广东、广西、河南和黑龙江的竞争优势明显,省内市场份额名列前茅。在中国药店年度发展报告会上,公司荣获“2025-2026中国药店价值榜100强”第一名;荣获由广东医药商业协会颁发的“2024年度中国药品零售企业销售总额10强”;荣获中国药店颁发的“中国药店25周年影响力人物/品牌”;荣获广东工商业联合会颁发的“广东省百强民营企业”第55位及“广东省服务业民营企业50强”第18位;荣获由同花顺与财闻传联合主办的“2025财闻奖”颁发的“高质量上市公司奖”。
发行价格:
24.72
{"stockData":{"symbol":"603233","market":"SH","secType":"STK","nameCN":"大参林","latestPrice":16.15,"timestamp":1782889201000,"preClose":15.03,"halted":0,"volume":13120235,"delay":0,"changeRate":0.0745,"floatShares":1139000000,"shares":1139000000,"eps":1.1296,"marketStatus":"已收盘","change":1.12,"latestTime":"07-01 15:00:00","open":15.11,"high":16.28,"low":14.81,"amount":206000000,"amplitude":0.0978,"askPrice":16.15,"askSize":10,"bidPrice":16.14,"bidSize":5,"shortable":0,"etf":0,"ttmEps":1.1296,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1782955800000},"marketStatusCode":5,"adr":0,"adjPreClose":15.03,"symbolType":"stock","openAndCloseTimeList":[[1782869400000,1782876600000],[1782882000000,1782889200000]],"highLimit":16.53,"lowLimit":13.53,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1138854520,"isCdr":false,"pbRate":2.39,"roa":"--","peRate":14.297096,"roe":"6.3%","epsLYR":1.08,"committee":-0.819975,"marketValue":18393000000,"turnoverRate":0.0115,"status":0,"floatMarketCap":18393000000},"requestUrl":"/m/hq/s/603233","defaultTab":"news","newsList":[{"id":"2648544147","title":"大参林(603233)披露可转债转股结果暨股份变动公告,7月1日股价上涨7.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648544147","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648544147?lang=zh_cn&edition=full","pubTime":"2026-07-01 23:13","pubTimestamp":1782918795,"startTime":"0","endTime":"0","summary":"截至2026年7月1日收盘,大参林报收于16.15元,较前一交易日上涨7.45%,最新总市值为183.93亿元。近日,大参林医药集团股份有限公司披露《可转债转股结果暨股份变动公告》。公告显示,截至2026年6月30日,累计有477,000元“大参转债”转换为公司股份,占可转债发行总量的0.0340%,累计转股数量12,867股,占可转债转股前公司已发行股份总额的0.0020%。2026年第二季度新增转股6,453股。股本变动方面,无限售条件流通股因转股增加6,453股,总股本相应增加。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100044009.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0209","BK0114","603233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648515055","title":"7月1日大参林涨7.45%,兴全有机增长混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2648515055","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648515055?lang=zh_cn&edition=full","pubTime":"2026-07-01 16:35","pubTimestamp":1782894929,"startTime":"0","endTime":"0","summary":"证券之星消息,7月1日大参林涨7.45%,收盘报16.15元,换手率1.15%,成交量13.12万手,成交额2.06亿元。根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共9家,其中持有数量最多的公募基金为兴证全球基金的兴全有机增长混合。兴全有机增长混合的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100031134.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603233","BK0185","BK0114","BK0209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648515035","title":"大参林涨7.45%,中邮证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2648515035","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648515035?lang=zh_cn&edition=full","pubTime":"2026-07-01 16:35","pubTimestamp":1782894918,"startTime":"0","endTime":"0","summary":"今日大参林(603233)涨7.45%,收盘报16.15元。2026年4月28日,中邮证券研究员盛丽华,龙永茂发布了对大参林的研报《利润增长超预期,多举措提升业绩释放潜力》,该研报对大参林给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算,该研报作者对此股的盈利预测准确度为82.33%。此外,东吴证券研究员朱国广,冉胜男,苏丰,国金证券研究员甘坛焕,王奔奔近期也对该股发布了研报,同样给出“买入”评级。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为西部证券的陆伏崴。大参林(603233)个股概况:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100031131.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","603233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647702983","title":"大参林(603233)披露2025年度可转债受托管理事务报告,6月29日股价上涨4.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647702983","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647702983?lang=zh_cn&edition=full","pubTime":"2026-06-29 22:38","pubTimestamp":1782743900,"startTime":"0","endTime":"0","summary":"截至2026年6月29日收盘,大参林报收于15.48元,较前一交易日上涨4.59%,最新总市值为176.29亿元。该股当日开盘14.8元,最高15.66元,最低14.39元,成交额达1.2亿元,换手率为0.69%。近日,大参林医药集团股份有限公司发布了《公开发行可转换公司债券受托管理事务报告》,披露了“大参转债”的发行概况、募集资金使用情况、债券受托管理人履职情况、发行人2025年度经营与财务状况、债券付息及跟踪评级情况。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900041468.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603233","BK0185","BK0114","BK0209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646249315","title":"每周股票复盘:大参林(603233)主体信用评级维持AA","url":"https://stock-news.laohu8.com/highlight/detail?id=2646249315","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646249315?lang=zh_cn&edition=full","pubTime":"2026-06-28 03:45","pubTimestamp":1782589513,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘,大参林报收于14.8元,较上周的16.15元下跌8.36%。本周,大参林6月23日盘中最高价报16.29元。公司公告汇总中证鹏元对大参林医药集团股份有限公司相关债券进行2026年跟踪评级,维持主体信用等级AA,评级展望稳定,大参转债信用等级AA。经中证鹏元资信评估股份有限公司评定,公司主体信用评级为“AA”,“大参转债”评级为“AA”,评级展望为“稳定”,与前次评级结果一致。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062800001171.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646933092","title":"6月26日XD大参林创60日新低,兴全有机增长混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2646933092","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646933092?lang=zh_cn&edition=full","pubTime":"2026-06-26 16:34","pubTimestamp":1782462857,"startTime":"0","endTime":"0","summary":"证券之星消息,6月26日XD大参林创60日新低,收盘报14.8元,当日跌4.08%,换手率0.52%,成交量5.9万手,成交额8863.25万元。根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共9家,其中持有数量最多的公募基金为兴证全球基金的兴全有机增长混合。兴全有机增长混合的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600030123.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603233","BK0185","BK0114","BK0209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644066882","title":"每周股票复盘:大参林(603233)每股派息0.49元6月26日发放","url":"https://stock-news.laohu8.com/highlight/detail?id=2644066882","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644066882?lang=zh_cn&edition=full","pubTime":"2026-06-20 03:27","pubTimestamp":1781897230,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘,大参林报收于16.15元,较上周的17.18元下跌6.0%。本周,大参林6月15日盘中最高价报17.4元。本周关注点公司公告汇总:大参林2025年年度权益分派每股现金红利0.49元,股权登记日为2026年6月25日,除权(息)日及现金红利发放日为2026年6月26日。公司公告汇总:因股份回购,大参林2025年度权益分派为差异化分派,实际参与分配股份数为1,132,132,266股。转债于2026年6月17日至6月25日期间停止转股,6月26日起恢复转股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062000002042.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","603233","BK0209","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644742134","title":"大参林(603233)披露2025年年度权益分派实施公告,6月17日股价下跌3.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644742134","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644742134?lang=zh_cn&edition=full","pubTime":"2026-06-17 22:46","pubTimestamp":1781707576,"startTime":"0","endTime":"0","summary":"截至2026年6月17日收盘,大参林报收于16.07元,较前一交易日下跌3.13%,最新总市值为183.01亿元。该股当日开盘16.53元,最高16.61元,最低15.97元,成交额达8535万元,换手率为0.46%。近日,大参林医药集团股份有限公司发布《2025年年度权益分派实施公告》:每股现金红利0.49元,股权登记日为2026年6月25日,除权(息)日及现金红利发放日均为2026年6月26日。本次分红涉及差异化分派,因公司回购股份不参与分配,实际参与分配股份数为1,132,132,266股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061700042459.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","BK0114","603233","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644712417","title":"大参林跌3.13% 中泰证券国金证券华西证券高位喊买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2644712417","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644712417?lang=zh_cn&edition=full","pubTime":"2026-06-17 17:26","pubTimestamp":1781688367,"startTime":"0","endTime":"0","summary":"中国经济网北京6月17日讯 大参林 股价今日下跌,截至收盘报16.07元,跌幅3.13%。 2021年1月25日,大参林股价在盘中创下上市以来最高价106.50元。 大参林于2021年6月3日公告称,每股派发现金红利0.8元(含税),以资本公积金向全体股东每股转增0.2股,除权除息日2021年6月10日,股权登记日2021年6月9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260617/32282656.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0028","BK0185","BK0276","BK0209","BK0188","BK0183","BK0114","BK0012","603233","BK0201","600918","002926","600109"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640976052","title":"濮阳大参林某门店登通报 售卖中药熏蒸仪抽检不合格","url":"https://stock-news.laohu8.com/highlight/detail?id=2640976052","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640976052?lang=zh_cn&edition=full","pubTime":"2026-06-03 14:17","pubTimestamp":1780467423,"startTime":"0","endTime":"0","summary":"中国经济网北京6月3日讯 河南省药品监督管理局5月29日发布河南省药品监督管理局医疗器械质量公告(2026年第1期)。河南省药品监督管理局组织各地监管部门对全省的医疗器械产品进行了监督抽检。\r\n\r\n 其中,陕西舒馫医疗器械科技有限公司生产的1批次中药熏蒸仪,规格型号:SX/XZ313A,批号:210820,不合格项目:缺水报警提示功能。受检单位为濮阳大参林连锁药店有限公司龙城广场店。\r\n\r\n \r\n\r\n 大参林(603233.SH)年报显示,濮阳大参林连锁药店有限公司为上市公司子公司。\r\n\r\n (责任编辑:徐自立)","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202606/03/20260603397928.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202606/03/20260603397928.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260603/32268629.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0185","603233","BK0209","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639040616","title":"每周股票复盘:大参林(603233)为8家子公司担保4.35亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2639040616","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639040616?lang=zh_cn&edition=full","pubTime":"2026-05-31 04:22","pubTimestamp":1780172532,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘,大参林报收于16.5元,较上周的17.28元下跌4.51%。本周,大参林5月25日盘中最高价报17.3元。本周关注点公司公告汇总:大参林为8家控股子公司提供合计43,500万元连带责任担保。大参林医药集团股份有限公司2020年员工持股计划存续期将于2026年12月3日届满。截至公告日,该员工持股计划持有公司股票6,572,239股,占公司总股本的0.58%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026053100001348.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603233","BK0185","BK0209","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638894896","title":"大参林(603233)披露对子公司提供担保的进展公告,5月27日股价下跌2.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638894896","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638894896?lang=zh_cn&edition=full","pubTime":"2026-05-27 22:42","pubTimestamp":1779892940,"startTime":"0","endTime":"0","summary":"截至2026年5月27日收盘,大参林报收于16.56元,较前一交易日下跌2.82%,最新总市值为188.59亿元。近日,大参林医药集团股份有限公司发布《关于对子公司提供担保的进展公告》。本次担保在公司2025年年度股东会审议通过的88.2亿元担保额度内,未提供反担保。截至公告日,公司及子公司对外担保总额为458,150万元,占最近一期经审计净资产的52.9%,均为对控股子公司的担保,无逾期担保。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052700046371.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0114","BK0209","603233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637752073","title":"每周股票复盘:大参林(603233)2025年年度股东会顺利召开","url":"https://stock-news.laohu8.com/highlight/detail?id=2637752073","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637752073?lang=zh_cn&edition=full","pubTime":"2026-05-24 04:11","pubTimestamp":1779567068,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘,大参林报收于17.28元,较上周的18.81元下跌8.13%。本周关注点公司公告汇总:大参林2025年年度股东会于2026年5月18日召开,审议通过利润分配方案等多项议案,出席股东所持表决权股份占比75.1865%公司公告汇总大参林医药集团股份有限公司2025年年度股东会于2026年5月18日召开,会议由董事会召集,董事谭群飞主持,采用现场与网络投票方式举行,出席股东所持表决权股份占公司有表决权总股份的75.1865%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400001275.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","603233","BK0185","BK0209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636071085","title":"大参林(603233)披露2025年年度股东会决议公告,5月18日股价下跌5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636071085","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636071085?lang=zh_cn&edition=full","pubTime":"2026-05-18 22:15","pubTimestamp":1779113718,"startTime":"0","endTime":"0","summary":"截至2026年5月18日收盘,大参林报收于17.79元,较前一交易日下跌5.42%,最新总市值为202.6亿元。该股当日开盘18.81元,最高18.82元,最低17.14元,成交额达3.65亿元,换手率为1.82%。近日,大参林医药集团股份有限公司披露《2025年年度股东会决议公告》。公告显示,公司于2026年5月18日召开2025年年度股东会,会议由董事会召集,董事谭群飞主持,采用现场与网络投票方式举行,出席股东所持表决权股份占公司有表决权总股份的75.1865%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800037321.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0114","BK0209","603233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636002980","title":"大参林跌5.42% 华创证券上周四刚维持推荐评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2636002980","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636002980?lang=zh_cn&edition=full","pubTime":"2026-05-18 17:17","pubTimestamp":1779095823,"startTime":"0","endTime":"0","summary":"中国经济网北京5月18日讯 大参林(603233.SH)股价今日下跌,截至收盘报17.79元,跌幅5.42%。\r\n\r\n 华创证券有限责任公司研究员郑辰、高初蕾5月14日发布研报《大参林(603233)2025年报及2026年一季报点评:盈利能力持续改善 大举分红回报股东》称,维持“推荐”评级。\r\n\r\n (责任编辑:徐自立)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260518/32233120.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["603233","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636102564","title":"5月18日大参林跌5.42%,兴全有机增长混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2636102564","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636102564?lang=zh_cn&edition=full","pubTime":"2026-05-18 16:34","pubTimestamp":1779093254,"startTime":"0","endTime":"0","summary":"证券之星消息,5月18日大参林跌5.42%,收盘报17.79元,换手率1.82%,成交量20.7万手,成交额3.65亿元。重仓大参林的公募基金请见下表:该股最近90天内共有9家机构给出评级,买入评级8家,增持评级1家;过去90天内机构目标均价为25.21。根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共9家,其中持有数量最多的公募基金为兴证全球基金的兴全有机增长混合。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202605/18/20260518757215.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202605/18/20260518757215.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260518/32232982.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0185","BK0209","603233","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634641218","title":"每周股票复盘:大参林(603233)2025年净利增35.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2634641218","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634641218?lang=zh_cn&edition=full","pubTime":"2026-05-10 03:33","pubTimestamp":1778355190,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘,大参林报收于18.55元,较上周的18.72元下跌0.91%。2025年实现营业收入275.02亿元,同比增长3.8%;归母净利润12.35亿元,同比增长35.04%。大参林医药集团股份有限公司将于2026年5月18日16:00-17:00通过上证路演中心网络互动方式召开2025年度暨2026年第一季度业绩说明会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000001429.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0209","603233","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633443284","title":"大参林(603233)披露2025年度股东会会议材料,5月8日股价上涨0.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633443284","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633443284?lang=zh_cn&edition=full","pubTime":"2026-05-08 18:12","pubTimestamp":1778235135,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘,大参林报收于18.55元,较前一交易日上涨0.32%,最新总市值为211.26亿元。该股当日开盘18.48元,最高18.89元,最低18.32元,成交额达1.2亿元,换手率为0.57%。近日,大参林医药集团股份有限公司披露2025年度股东会会议材料。2025年实现营业收入275.02亿元,同比增长3.8%;归母净利润12.35亿元,同比增长35.04%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800033464.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0114","BK0209","603233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630589762","title":"中邮证券:给予大参林买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2630589762","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630589762?lang=zh_cn&edition=full","pubTime":"2026-04-28 23:45","pubTimestamp":1777391121,"startTime":"0","endTime":"0","summary":"中邮证券有限责任公司盛丽华,龙永茂近期对大参林进行研究并发布了研究报告《利润增长超预期,多举措提升业绩释放潜力》,给予大参林买入评级。 盈利预测及投资建议 公司顺应行业周期,提质增效,利润释放潜力大,我们预计公司2026~2028营收分别为303.60、336.04、371.96亿元,归母净利润分别为14.86、16.57、18.76亿元,当前股价对应PE分别为14、13、11倍,维持“买入”评级。最新盈利预测明细如下:该股最近90天内共有3家机构给出评级,买入评级3家。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800068209.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","603233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630322093","title":"股市必读:大参林年报 - 第四季度单季净利润同比增长172.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630322093","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630322093?lang=zh_cn&edition=full","pubTime":"2026-04-27 08:05","pubTimestamp":1777248322,"startTime":"0","endTime":"0","summary":"来自:2025年第四季度归母净利润同比上升172.37%,扣非净利润同比增幅达363.93%。股本股东变化股东户数变动近日大参林披露,截至2026年3月31日公司股东户数为2.54万户,较12月31日减少2706.0户,减幅为9.62%。大参林医药集团股份有限公司2025年度审计报告大参林医药集团股份有限公司2025年度财务报告由天健会计师事务所审计,审计意见为标准无保留意见。2025年度营业收入为2,750,218.84万元,同比增长3.80%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700007448.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603233"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1782926453398,"stockEarnings":[{"period":"1week","weight":0.0471},{"period":"1month","weight":0.0018},{"period":"3month","weight":-0.0718},{"period":"6month","weight":-0.0544},{"period":"1year","weight":0.0247},{"period":"ytd","weight":-0.0544}],"compareEarnings":[{"period":"1week","weight":0.0004},{"period":"1month","weight":0.0135},{"period":"3month","weight":0.0493},{"period":"6month","weight":0.0362},{"period":"1year","weight":0.1893},{"period":"ytd","weight":0.0362}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"大参林医药集团股份有限公司","boardCode":"AI0052","boardName":"零售业","stockholders":"25410人(较上一季度减少9.62%)","perCapita":"44819股","listingDate":"2017-07-31","address":"广东省广州市荔湾区龙溪大道410号、410-1号","registeredCapital":"113885万元","survey":" 大参林医药集团股份有限公司的主营业务是中西成药、参茸滋补药材及中药饮片、保健品、医疗器械及其他商品的连锁零售业务。公司的主要产品是中西成药、中参药材、非药品。公司荣获的社会地位及行业荣誉:“大参林”已成为“中国驰名商标”和“广东省著名商标”。公司业务范围覆盖广东、广西、河南、黑龙江、江苏、新疆、辽宁、四川、重庆、河北、陕西、江西、山西、浙江、湖北、山东、福建、安徽、海南、上海、内蒙古等21个省(含自治区、直辖市),其中,广东、广西、河南和黑龙江的竞争优势明显,省内市场份额名列前茅。在中国药店年度发展报告会上,公司荣获“2025-2026中国药店价值榜100强”第一名;荣获由广东医药商业协会颁发的“2024年度中国药品零售企业销售总额10强”;荣获中国药店颁发的“中国药店25周年影响力人物/品牌”;荣获广东工商业联合会颁发的“广东省百强民营企业”第55位及“广东省服务业民营企业50强”第18位;荣获由同花顺与财闻传联合主办的“2025财闻奖”颁发的“高质量上市公司奖”。","listedPrice":24.72},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"大参林(603233)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供大参林(603233)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"大参林,603233,大参林股票,大参林股票老虎,大参林股票老虎国际,大参林行情,大参林股票行情,大参林股价,大参林股市,大参林股票价格,大参林股票交易,大参林股票购买,大参林股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"大参林(603233)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供大参林(603233)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}